How many insider declarations has Nunn Jason Raleigh filed?

Nunn Jason Raleigh has filed 4 public insider declarations with SEC (Form 4).

What is Nunn Jason Raleigh's role?

Nunn Jason Raleigh's reported role is not specified by the regulator across the filings.

Which companies does Nunn Jason Raleigh report trades for?

Nunn Jason Raleigh reports trades for 2 companies, including Regulus Therapeutics Inc..

What is Nunn Jason Raleigh's declared buy vs sell volume?

Across the available history, declared buys total 1.0M€ and disposals 0.

← Executives ★ Sign in to follow

NJ

Nunn Jason Raleigh

OFFICER

·SEC (Form 4)

Regulus Therapeutics Inc.Zenas BioPharma, Inc.

0

Total declarations

0

Companies

€1m

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Browse the full record of transactions filed by Nunn Jason Raleigh. Director active across 2 companies, notably Regulus Therapeutics Inc.. In total, 4 reports have been recorded. Split: 1 buy · 0 sell. Total volume traded: €1m. Activity tracked since 30 April 2025. The latest transaction was filed on 9 October 2025 (Acquisition). Regulator: SEC (Form 4). The full history is free.

Companies and markets linked to Nunn Jason Raleigh

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Regulus Therapeutics Inc. (US)Zenas BioPharma, Inc. (US)

Declarations4 total

▲

Nunn Jason Raleigh

DirectorExecutives9 Oct 2025Zenas BioPharma, Inc.

$1M0SEC ↗

63,158 shares@ US$19.00Common StockSEC:0001193125-25-239158:0

Canonical exit: 7 Jan 2026 (T+90)

●

Nunn Jason Raleigh

DirectorExecutives25 Jun 2025Regulus Therapeutics Inc.

11SEC ↗

62,500 sharesCommon StockSEC:0000950170-25-091006:0

◆

Nunn Jason Raleigh

DirectorExecutives30 Apr 2025Regulus Therapeutics Inc.

11SEC ↗

62,500 shares0Common StockSEC:0000950170-25-061298:0

●

Nunn Jason Raleigh

DirectorExecutives16 Sept 2024Zenas BioPharma, Inc.

11SEC ↗

1,505,388 sharesCommon StockSEC:0000950170-24-106979:0

4 of 4 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

NJ

Nunn Jason Raleigh

OFFICER

·SEC (Form 4)

Regulus Therapeutics Inc.Zenas BioPharma, Inc.

0

Total declarations

0

Companies

€1m

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Browse the full record of transactions filed by Nunn Jason Raleigh. Director active across 2 companies, notably Regulus Therapeutics Inc.. In total, 4 reports have been recorded. Split: 1 buy · 0 sell. Total volume traded: €1m. Activity tracked since 30 April 2025. The latest transaction was filed on 9 October 2025 (Acquisition). Regulator: SEC (Form 4). The full history is free.